Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep 27:2018:6238978.
doi: 10.1155/2018/6238978. eCollection 2018.

Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy

Affiliations
Review

Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy

Duale Ahmed et al. Mediators Inflamm. .

Abstract

With the advent of antiretroviral therapy (ART), HIV-infected individuals are now living longer and healthier lives. However, ART does not completely restore health and treated individuals are experiencing increased rates of noncommunicable diseases such as dyslipidemia, insulin resistance, type 2 diabetes, cardiovascular disease, and nonalcoholic fatty liver disease. While it is well known that persistent immune activation and inflammation contribute to the development of these comorbid diseases, the mechanisms underlying this chronic activation remain incompletely understood. In this review, we will discuss emerging evidence that suggests that alterations in cellular metabolism may play a central role in driving this immune dysfunction in HIV patients on ART.

PubMed Disclaimer

Similar articles

Cited by

References

    1. van Sighem A., Gras L. A., Reiss P., Brinkman K., de Wolf F., ATHENA national observational cohort study Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS. 2010;24(10):1527–1535. doi: 10.1097/QAD.0b013e32833a3946. - DOI - PubMed
    1. Antiretroviral Therapy Cohort Collaboration, Zwahlen M., Harris R., et al. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. International Journal of Epidemiology. 2009;38(6):1624–1633. doi: 10.1093/ije/dyp306. - DOI - PMC - PubMed
    1. Pacheco Y. M., Jarrin I., Rosado I., et al. Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort. Antiviral Research. 2015;117:69–74. doi: 10.1016/j.antiviral.2015.03.002. - DOI - PubMed
    1. Guaraldi G., Orlando G., Zona S., et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clinical Infectious Diseases. 2011;53(11):1120–1126. doi: 10.1093/cid/cir627. - DOI - PubMed
    1. Hsu D. C., Sereti I., Ananworanich J. Serious non-AIDS events: immunopathogenesis and interventional strategies. AIDS Research and Therapy. 2013;10(1):p. 29. doi: 10.1186/1742-6405-10-29. - DOI - PMC - PubMed

MeSH terms

Substances